G01N 33/5014
For testing toxicity
Official title: {for testing toxicity}
G01N33/5014 (For testing toxicity) appears on 1,219 US grants and 2,166 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,219
- Published applications
- 2,166
- Assignees
- 912
- Inventors
- 3,534
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 8 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 8 | 0 |
| 1994 | 8 | 0 |
| 1995 | 6 | 0 |
| 1996 | 10 | 0 |
| 1997 | 21 | 0 |
| 1998 | 33 | 0 |
| 1999 | 31 | 0 |
| 2000 | 32 | 0 |
| 2001 | 36 | 7 |
| 2002 | 27 | 46 |
| 2003 | 24 | 502 |
| 2004 | 16 | 89 |
| 2005 | 24 | 78 |
| 2006 | 38 | 81 |
| 2007 | 87 | 76 |
| 2008 | 93 | 51 |
| 2009 | 36 | 64 |
| 2010 | 28 | 53 |
| 2011 | 16 | 63 |
| 2012 | 33 | 70 |
| 2013 | 37 | 52 |
| 2014 | 37 | 86 |
| 2015 | 43 | 84 |
| 2016 | 39 | 60 |
| 2017 | 44 | 84 |
| 2018 | 46 | 82 |
| 2019 | 46 | 85 |
| 2020 | 46 | 92 |
| 2021 | 40 | 74 |
| 2022 | 53 | 87 |
| 2023 | 36 | 56 |
| 2024 | 37 | 47 |
| 2025 | 46 | 63 |
| 2026 | 22 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Single-cell-based electrochemical sensor based on functionalized nano-probe and application thereof6 Oct 2026US 12,754,158 B2Jiangnan University
- Extraction methods for evaluating suitability of a biochemical filter6 Oct 2026US 12,754,181 B2Regeneron Pharmaceuticals, Inc.
- IFNβ as a pharmacodynamic marker in VSV-IFNβ-NIS oncolytic therapy6 Oct 2026US 12,754,182 B2Mayo Foundation for Medical Education and Research
- Device for evaluation of chemical substance and method for evaluation of chemical substance16 Jun 2026US 12,655,379 B2Public University Corporation Nagoya City University
- Encapsulated liver tissue16 Jun 2026US 12,655,392 B2Morphocell Technologies Inc.
- Pluripotent stem cell-derived rpe cell, preparation, pharmaceutical composition, reagent, method, and kit1 Oct 2026US 2026/0297515 A1Help Regenerative Medicine Technology (Shenzhen) Co., Ltd.
- Application of a brain organoid model for simulating the damage of environmental pollutants to brain development during embryonic period24 Sep 2026US 2026/0287574 A1Tianjin University
- Applications of hepatocyte co-culture system24 Sep 2026US 2026/0287577 A1LifeNet Health
- Prophylactic or therapeutic against exacerbation or recurrence of cancer, and screening method therefor17 Sep 2026US 2026/0276624 A1
- Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications13 Aug 2026US 2026/0235578 A1Tabula Rasa Healthcare, Inc.
Most cited
By later US patents
- Transgenic non-human mammals531US 4,736,866 APresident and Fellows of Harvard College · 1988
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Cell viability detection using electrical measurements228US 6,927,049 B2The Regents of the University of California · 2005
- Reconstituted basement membrane complex with biological activity212US 4,829,000 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989